Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132333) titled 'Plasma Metabolomics Study in Cardiorenal Metabolic Syndrome' on Sept. 11.

Study Type: Diagnostic test

Study Design: Diagnostic test: case-control

Primary Sponsor: Ningbo No.2 Hospital

Condition: Cardio-renal metabolic syndrome, obesity, chronic kidney disease, cardiovascular disease

Intervention: Gold Standard:Cardiovascular disease, obesity, chronic kidney disease, metabolic syndrome

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-11

Target Sample Size: Target condition:400;Difficult condition:100

Countries of Recruitment: China

To know more, visit https://www.ch...